মাথা ও ঘাড়ের ক্যান্সার
The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas
কোথায় যেতে হবে
ভারতের ১টি হাসপাতালে এই ট্রায়ালের জন্য রোগী নেওয়া হচ্ছে।
রেজিস্ট্রির সারসংক্ষেপ (টেকনিক্যাল)
The aim of SWOAR TRIAL is to test sparing of Dysphagia/ Aspiration risk structures (DARS) and contra lateral submandibular gland by IMRT. HNSCC of the oropharynx, larynx and the hypopharynx treated with radical concurrent chemoradiotherapy or radiotherapy will be included in the trial. Patients will be randomized to SWOAR IMRT or standard IMRT. Swallowing function will be evaluated the MD Anderson Dysphagia Inventory (MDADI) scoring. Difference in the mean composite score of MDADI, a patient-reported outcome, at 6 months post radiotherapy is the primary outcome of the trial. Secondary Object…
Sponsor: All India Institute of Medical Sciences
NCT05187091 on ClinicalTrials.gov
Last updated on the registry 11 Sep 2026 · read by us 20 Oct 2026